Hvivo PLC Company Profile (LON:HVO)

About Hvivo PLC (LON:HVO)

Hvivo PLC logohVIVO plc, formerly Retroscreen Virology Group plc, is a holding company. The Company is engaged in a life sciences business pioneering a technology platform of human disease models to accelerate drug discovery and development in respiratory and infectious diseases, including flu, respiratory syncytial virus (RSV), asthma and common cold. It has commercialized approximately four disease models, enrolled over 2,000 subjects and conducted approximately 40 product validation studies for a range of industry, government and academic clients and collaborators. The Company offers services, such as challenge study services, lab services, and target and biomarker discovery. It offers viral challenge studies in healthy volunteers in influenza, human rhinovirus (HRV) and RSV. Its lab services include assay development, transfer and optimization across the immunological, molecular and cell-based assay platforms, including offering options in sample matrix testing and specialty biomarker assays.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Healthcare Facilities & Services - NEC
  • Sub-Industry: N/A
  • Symbol: LON:HVO
  • CUSIP: N/A
  • Web: hvivo.com/
Capitalization:
  • Market Cap: £58.97 million
  • Outstanding Shares: 78,101,000
Average Prices:
  • 50 Day Moving Avg: GBX 93.34
  • 200 Day Moving Avg: GBX 133
  • 52 Week Range: GBX 69.89 - GBX 239.75
P/E:
  • Trailing P/E Ratio: N/A
  • P/E Growth: 0.00
Sales & Book Value:
  • Annual Revenue: £19.85 million
  • Price / Sales: 2.97
  • Book Value: GBX 0.59 per share
  • Price / Book: 1.28
Profitability:
  • EBIDTA: ($13,980,000.00)
  • Net Margins: -73.08%
  • Return on Equity: -32.75%
  • Return on Assets: -25.48%
Misc:
  • Average Volume: 19,113 shs.
 
Frequently Asked Questions for Hvivo PLC (LON:HVO)

What is Hvivo PLC's stock symbol?

Hvivo PLC trades on the London Stock Exchange (LON) under the ticker symbol "HVO."

When will Hvivo PLC make its next earnings announcement?

Hvivo PLC is scheduled to release their next quarterly earnings announcement on Wednesday, September, 20th 2017. View Earnings Estimates for Hvivo PLC.

Where is Hvivo PLC's stock going? Where will Hvivo PLC's stock price be in 2017?

1 analysts have issued 1 year target prices for Hvivo PLC's stock. Their predictions range from GBX 150 to GBX 150. On average, they anticipate Hvivo PLC's stock price to reach GBX 150 in the next year. View Analyst Ratings for Hvivo PLC.

Who are some of Hvivo PLC's key competitors?

Who are Hvivo PLC's key executives?

Hvivo PLC's management team includes the folowing people:

  • Kimberly Lynn Denny, Chief Executive Officer, Executive Director
  • Graham Yeatman, Chief Financial Officer, Executive Director, Business Officer
  • Jaime Wallace Ellertson, Non-Executive Chairman
  • Trevor J. Nicholls Ph.D., Non-Executive Director
  • Mark Robert Warne, Non-Executive Director
  • James Francis Winschel Jr., Non-Executive Director

How do I buy Hvivo PLC stock?

Shares of Hvivo PLC and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is Hvivo PLC's stock price today?

One share of Hvivo PLC stock can currently be purchased for approximately GBX 75.50.


MarketBeat Community Rating for Hvivo PLC (LON HVO)
Community Ranking:  1.8 out of 5 ()
Outperform Votes:  14 (Vote Outperform)
Underperform Votes:  26 (Vote Underperform)
Total Votes:  40
MarketBeat's community ratings are surveys of what our community members think about Hvivo PLC and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Hvivo PLC (LON:HVO) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 1 Hold Rating
Consensus Rating:Hold (Score: 2.00)
Consensus Price Target: GBX 150

Analysts' Ratings History for Hvivo PLC (LON:HVO)
Show:
DateFirmActionRatingPrice TargetDetails
4/20/2017Numis Securities LtdReiterated RatingAddGBX 150View Rating Details
(Data available from 7/23/2015 forward)

Earnings

Earnings History for Hvivo PLC (LON:HVO)
Earnings by Quarter for Hvivo PLC (LON:HVO)
Earnings History by Quarter for Hvivo PLC (LON HVO)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
9/20/2017N/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Hvivo PLC (LON:HVO)
Current Year EPS Consensus Estimate: $-17.00 EPS

Dividends

Dividend History for Hvivo PLC (LON:HVO)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for Hvivo PLC (LON:HVO)
Insider Trades by Quarter for Hvivo PLC (LON:HVO)
Insider Trades by Quarter for Hvivo PLC (LON:HVO)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
7/7/2017Jaime EllertsonInsiderBuy16,888GBX 89£15,030.32
4/4/2017Jaime EllertsonInsiderBuy12,508GBX 128£16,010.24
1/4/2017Jaime EllertsonInsiderBuy10,114GBX 161£16,283.54
10/11/2016James WinschelInsiderBuy2,221GBX 180£3,997.80
8/3/2016Ellertson,JaimeInsiderBuy7,801GBX 187£14,587.87
4/13/2016Ellertson,JaimeInsiderBuy7,731GBX 182£14,070.42
5/6/2015James WinschelInsiderBuy8,000GBX 321.60£25,728
4/23/2015James WinschelInsiderBuy12,350GBX 330£40,755
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for Hvivo PLC (LON:HVO)
Latest Headlines for Hvivo PLC (LON:HVO)
Source:
DateHeadline
americanbankingnews.com logoJaime Ellertson Acquires 16,888 Shares of Hvivo PLC (HVO) Stock
www.americanbankingnews.com - July 10 at 7:50 AM
americanbankingnews.com logoHvivo PLC (HVO) Rating Reiterated by Numis Securities Ltd
www.americanbankingnews.com - April 20 at 1:36 PM
americanbankingnews.com logoHvivo PLC (HVO) Insider Jaime Ellertson Purchases 12,508 Shares
www.americanbankingnews.com - April 5 at 4:43 AM
lse.co.uk logoData from PrEP Biopharm's Ph. IIa clinical studies - London South East (registration) (blog)
www.lse.co.uk - February 9 at 11:42 PM
biz.yahoo.com logoHalf Year 2016 Hvivo PLC Earnings Release - Time Not Supplied
biz.yahoo.com - September 22 at 8:39 AM
uk.finance.yahoo.com logohVIVO Announces a Joint Venture Investment with the SEEK Group to Develop Vaccines against Flu and Zika Infections
uk.finance.yahoo.com - April 22 at 2:03 PM
bloomberg.com logoDuncan Joseph Peyton
www.bloomberg.com - January 28 at 2:01 PM
bloomberg.com logoAlison Margaret Fielding Ph.D.
www.bloomberg.com - January 17 at 12:52 PM

Social

Social activity is not available for this stock.

Chart

Hvivo PLC (HVO) Chart for Sunday, July, 23, 2017

This page was last updated on 7/23/2017 by MarketBeat.com Staff